2011 Biosimilars Compounding 
Pharmacy Times
JULY 26, 2025
Boehringer Ingelheim; 2011. Accessed June 4, 2025. link] Savaysa. Prescribing information. Daiichi Sankyo, Inc; 2015. Accessed June 4, 2025. link] Pradaxa. Prescribing information. Accessed June 4, 2025.
Pharmacy Times
AUGUST 14, 2025
doi:10.1136/practneurol-2011-000071 Stiff Person Syndrome. American Brain Foundation. Accessed August 14, 2025. link] Hadavi S, Noyce AJ, Leslie RD, Giovannoni G. Stiff person syndrome. Pract Neurol. 2011;11(5):272-282. Cleveland Clinic. Updated June 10, 2024. Accessed August 14, 2025.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
OCTOBER 23, 2024
Food and Drug Administration to bar compounding pharmacies from making copies of its blockbuster weight loss drug semaglutide, arguing that the medication is too complex for the pharmacies to safely make , STAT reports. Novo has repeatedly argued that compounded products are risky, stressing that they are not approved by the FDA.
Express Pharma
JUNE 5, 2023
billion in 2031 across the 8MM, registering a compound annual growth rate (CAGR) of 1.9 Jakafi’s landmark approval in 2011 galvanised intensive drug development efforts by providing a strong positive investment signal for this market, as Jakafi is a blockbuster agent. billion in 2021 to $2.89
European Pharmaceutical Review
JULY 4, 2024
4,6 Five patent issues that European biosimilar developers should consider before entering the US market Quality control of the botanical drug substances was one of the critical factors that led to barricades during the development of Veregen and Mytesi. 13 Currently, over 350 herbal remedies have been granted a THR licence. 2012/1916).
FDA Law Blog: Biosimilars
DECEMBER 3, 2023
As part of this change, the Coverage Gap Discount Program (CGDP), a program that has existed since 2011, will sunset on December 31, 2024, and be replaced by the Medicare Part D Manufacturer Discount Program (the “Discount Program”). Kirschenbaum — The Inflation Reduction Act (IRA) significantly changed the Part D benefit.
Expert insights. Personalized for you.
Let's personalize your content